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Abstract
Introduction In 2001, data from the California Cancer Registry
suggested that breast cancer incidence rates among non-
Hispanic white (nHW) women in Marin County, California, had
increased almost 60% between 1991 and 1999. This analysis
examines the extent to which these and other breast cancer
incidence trends could have been impacted by bias in
intercensal population projections.
Method We obtained population projections for the year 2000
projected from the 1990 census from the California Department
of Finance (DOF) and population counts from the 2000 US
Census for nHW women living in 10 California counties and
quantified age-specific differences in counts. We also
computed age-adjusted incidence rates of invasive breast
cancer in order to examine and quantify the impact of
differences between the population data sources.
Results Differences between year 2000 DOF projections and
year 2000 census counts varied by county and age and ranged
from underestimates of 60% to overestimates of 64%. For Marin
County, the DOF underestimated the number of nHW women
aged 45 to 64 years by 32% compared to the 2000 US census.
This difference produced a significant 22% discrepancy
between breast cancer incidence rates calculated using the two
population data sources. In Los Angeles and Santa Clara
counties, DOF-based incidence rates were significantly lower
than rates based on census data. Rates did not differ
significantly by population data source in the remaining seven
counties examined.
Conclusion Although year 2000 population estimates from the
DOF did not differ markedly from census counts at the state or
county levels, greater discrepancies were observed for race-
stratified, age-specific groups within counties. Because breast
cancer incidence rates must be calculated with age-specific
data, differences between population data sources at the age-
race level may lead to mis-estimation of breast cancer incidence
rates in county populations affected by these differences, as
was observed in Marin County. Although intercensal rates
based on population projections are important for timely breast
cancer surveillance, these rates are prone to bias due to the
error of closure between population projections and decennial
census population counts. Intercensal rates should be
interpreted with this potential bias in mind.
Introduction
From the inception of the Surveillance, Epidemiology, and End
Results (SEER) national cancer registry network in 1973,
Marin County, California, a small county near San Francisco,
has consistently reported higher than average annual inci-
dence rates of breast cancer. Averaged from 1973 to 1999,
Marin County reported the highest overall breast cancer inci-
dence rate of the 199 counties included in the SEER database
(based on the SEER 9 November 2001 submission released
April 2004) [1]. In recent years, reports of rapidly increasing
breast cancer rates in Marin County attracted public and
media attention. These reports suggested that overall age-
adjusted incidence rates of invasive breast cancer in non-His-
panic white (nHW) women living in Marin County had
increased approximately 60% between 1990 and 1999, as
compared to 5% in surrounding regions (Fig. 1) [2]. These
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trends have resulted in Marin County having one of the highest
incidence rates reported in the world and have prompted pub-
lic and scientific concern.
Several possible explanations have been suggested for these
breast cancer incidence patterns. Overall, the socio-demo-
graphic profile of most women living in Marin County would
suggest a higher prevalence of women with known risk factors
for breast cancer: relatively high proportions of the county
population are of nHW ethnicity and college-educated, and
the county has a median household income almost double the
national average (derived from data from Population estimates,
2000 Census of Population and Housing, 1990 Census of
Population and Housing, Small Area Income and Poverty Esti-
mates, County Business Patterns, 1997 Economic Census,
Minority- and Women-Owned Business, Building Permits,
Consolidated Federal Funds Report, 1997 Census of Govern-
ments [3]). In addition, women living in Marin County have
fewer children, report a later age at first childbirth, and have
higher rates of alcohol consumption than most areas of Cali-
fornia, all of which correspond to an increased risk of develop-
ing breast cancer [4-6].
Another possible explanation for the observed increase in
breast cancer incidence in Marin County during the 1990s
involves error in population estimates used in the calculation of
cancer rates. Intercensal population estimates, as are used to
calculate breast cancer incidence rates for Marin County, are
used by a variety of health surveillance organizations nation-
wide. In order to track changes in the occurrence of health out-
comes in a timely manner, disease registries, vital statistics
agencies, and local health departments must rely on timely
estimates of annual population size; however, for most locales
in the United States, the population is counted only once every
10 years as part of the national census. Population estimates
for intercensal years are projected from census counts from
the most recent decennial census along with other govern-
mental data (e.g., vital statistics and immigration records), and
are subject to adjustment after the release of data from the
subsequent census. The discrepancy between year 2000
population data from the 2000 census and population projec-
tions for the year 2000 based on the 1990 census is known
as the 'error of closure'.
In California, intercensal population projections are available
from two sources, the US Census Bureau and the California
Department of Finance (DOF). Although it is uncertain which
agency produces more accurate population projections, most
California health agencies rely on data from the DOF, perhaps
because the methodology used by the census includes little
county-specific information, because significant flaws in Cen-
sus Bureau-produced estimates have been cited in the past,
and because the DOF incorporates additional county- and
state-specific information into population projections [7-9]. In
order to project the size of the population of California by
county, gender, race/ethnicity, and 1 year age increments, for
the next 50 years, the DOF not only uses data from the most
recent national census, but also enhanced state data
resources, such as state records of drivers license change of
address transactions, migration patterns based on previous
censuses, ethnic group-specific fertility rates, information from
the Department of Corrections regarding the capacity and
flow of prisoners through facilities, and information from the
Pentagon to predict military base closures and reassignments.
The DOF also makes adjustments to all intercensal population
projections dating back to the previous national census with
the release of new national census counts [9,10].
Despite the detailed algorithm used by the DOF to project the
distribution and size of the California population, these projec-
tions are subject to the same limitations as intercensal popu-
lation figures generated by the Census Bureau; the risk of
inaccuracy increases as annual estimates become more tem-
porally removed from the most recent census. Furthermore,
estimates for small areas, or certain age, gender, and racial/
ethnic groups are prone to even larger biases due to algorithm
inaccuracies: areas with a high growth rate, a large population
of retirees, or a large population of foreign-born individuals are
likely to be underestimated, while areas with high poverty, and
areas with a negative growth rate are likely to be overestimated
[7].
The following analysis was conducted to assess the impact on
breast cancer incidence rates of the error of closure in strati-
fied DOF projections, 10 years removed from the most recent
national census. The goals of this analysis were: to examine
how closely population estimates for the year 2000 from the
Figure 1
Breast cancer incidence in Marin County, California, and surrounding  areas based on Department of Finance population projections for 1990  to 1999 Breast cancer incidence in Marin County, California, and surrounding 
areas based on Department of Finance population projections for 1990 
to 1999. Rates are age-adjusted to the 2000 US standard population, 
based on population data unadjusted to the 2000 US census. **Case 
data from the California Cancer Registry.
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California DOF correlated overall and for selected population
strata with counts from the 2000 US census; and to assess
how breast cancer incidence rates in selected California coun-
ties could be affected by the error of closure between DOF
estimates and census counts.
Materials and methods
Data sources and study population
At the time of this analysis, 10 counties in California partici-
pated in the National Cancer Institute's SEER program
(Alameda, Contra Costa, Marin, San Francisco, San Mateo,
Monterey, San Benito, Santa Clara, Santa Cruz, and Los
Angeles). Data on incident invasive breast cancers diagnosed
between 1999 and 2001 in these counties were accessed
with public-use SEER data files (based on the SEER 11 Sub
for Expanded Races November 2003 submission released
April 2004) [1].
Age, sex, and race/ethnicity-specific population data for the
year 2000 for counties under analysis were obtained from the
DOF and the US Census Bureau [9,11]. Year 2000 DOF esti-
mates used in these analyses were projected based on the
1990 census and were not adjusted to the 2000 census,
although DOF data adjusted to the 2000 census are now
available. Year 2000 data from the US Census represent
actual year 2000 counts.
Analyses were limited to nHW women. We limited the popula-
tion to this group to avoid confounding by race/ethnicity;
because breast cancer incidence rates are higher among
Table 1
Percent difference between DOF and census population estimates for non-Hispanic white women by age (2000)a
Age (years) Alameda Contra Costa Marin San Francisco San Mateo Monterey San Benito Santa Clara Santa Cruz Los Angeles
All ages 3.4 3.8 -1.4 -5.7 3.8 4.0 10.4 8.7 4.7 2.1
Under 5 8.5 -1.1 -5.1 23.2 1.5 19.2 6.0 5.2 11.5 0.8
5–14 13.2 <0.1 -1.5 64.1 9.2 27.7 -6.7 10.4 10.8 4.1
15–24 -3.7 26.8 40.0 -54.9 16.2 5.3 41.7 6.0 -3.8 -12.8
25–34 -19.5 -0.9 41.4 -60.3 -21.9 -11.4 15.4 -4.4 1.7 -11.1
35–44 9.2 -4.4 17.3 40.7 2.3 14.4 -8.0 14.8 4.3 13.6
45–54 10.9 4.7 -31.1 27.0 8.0 -2.5 -0.6 12.7 5.5 9.1
55–64 13.9 13.1 -32.9 11.4 14.5 -3.8 24.0 20.1 7.6 9.1
65–74 3.9 9.7 5.9 7.7 10.6 -2.3 47.0 13.0 8.8 -0.3
75–84 -4.4 -4.8 -5.8 9.1 2.6 -3.8 24.6 -2.1 5.2 -3.0
85+ -4.9 -10.3 -24.7 20.8 -2.8 -1.5 25.0 -14.5 3.3 2.8
aPercent difference = ([DOF - census]/census) × 100. DOF, Department of Finance.
Table 2
DOF-based versus census-based breast cancer incidence rates among non-Hispanic white women (1999–2001)
County Average cases per year DOF-based incidence rate 
(95% CI)a
Census-based incidence rate 
(95% CI)a
Standardized rate ratio
Alameda 575 143.3 (136.6–150.4) 151.8 (144.6–159.2) 0.94
Contra Costa 592 158.0 (150.7–165.7) 164.9 (157.2–172.9) 0.96
Marin 245 213.6 (198.4–229.9) 175.8 (163.2–189.5) 1.22b
San Francisco 296 140.3 (131.0–150.7) 159.8 (149.2–171.0) 0.88
San Mateo 406 152.3 (143.7–161.4) 163.4 (154.2–173.2) 0.93
Monterey 172 152.7 (139.7–166.9) 150.7 (137.7–164.8) 1.01
San Benito 19 114.0 (85.9–149.0) 138.7 (104.6–182.0) 0.82
Santa Clara 743 143.4 (137.5–149.5) 158.6 (152.0–165.4) 0.90
Santa Cruz 161 148.2 (135.1–162.4) 157.8 (143.8–173.0) 0.94b
Los Angeles 3587 153.8 (150.7–156.9) 161.0 (157.8–164.3) 0.96b
aIncidence rates are expressed per 100,000 women based on year 2000 population denominators. Data are adjusted to the 2000 US standard. 
bp < 0.05. DOF, Department of Finance.Breast Cancer Research    Vol 7 No 5    Phipps et al.
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nHW women than among women of any other race, to include
breast cancer incidence estimates for Los Angeles County
(where only 31% of the population is nHW) and estimates for
Marin County (where 79% of the population is nHW) in the
same analysis, without accounting for race, could be mislead-
ing [5]. There are, however, important differences in the way
the DOF and the census categorize race/ethnicity. The 2000
US Census allowed individuals to report up to six distinct eth-
nicities concurrently to categorize themselves, whereas the
DOF stratified the population into five mutually exclusive race
categories (white, Hispanic, African-American, Asian Pacific
Islander, and American Indian) [10,11]. To control for these
differences in race categorization, a US census dataset with
bridged race categories was used [12].
Comparison of population data
Year 2000 population data from the DOF and the census were
compared overall and stratified by county, gender, and age
group. We examined these stratified groups in order to identify
and describe those most likely to be impacted by discrepan-
cies in population estimates.
For all comparisons, 2000 census data were chosen as the
standard. Percent differences between data sources can thus
be interpreted as the percent by which DOF estimates overes-
timate or underestimate corresponding census counts. Very
small percent differences are to be expected due to the fact
that census estimates are based on the population as of 1
April 2000, whereas DOF estimates are based on the popula-
tion as of the middle of the year [10,11].
Analysis of incidence rates
For the comparison of breast cancer incidence rates, we
included cases of invasive breast cancer (classified as 50.0–
50.9 by the International Classification of Diseases; Oncology,
2nd edition) diagnosed between the years 1999 and 2001
[13]. County-specific incidence rates were age-adjusted using
direct-standardization methods, adjusting to the 2000 US
standard population [14]. Incidence rates based on year 2000
DOF population estimates, and their corresponding 95% con-
fidence intervals, were compared to incidence rates based on
year 2000 census counts for each county under analysis.
Standardized rate ratios were calculated to compare DOF-
based and census-based incidence rates for all counties
under analysis. Census-based rates were used as the refer-
ence in all regression models, such that rate ratios derived
from each of the 10 county-specific models describe the influ-
ence of discrepancies between rate denominators independ-
ent of the rate numerator.
Results
Overall, the DOF estimated the size of the year 2000 Califor-
nia population to be 2.3% larger than was counted by the cen-
sus. When restricted to nHW women in the 10 counties under
analysis, DOF population estimates exceeded census counts
by approximately 2.9%, ranging from 5.7% below census
counts in San Francisco County to 10.4% above census
counts in San Benito County. Table 1 summarizes discrepan-
cies between population data sources by age strata and
county.
When further stratified by age group, DOF and census county
population data for nHW women differed more significantly,
although patterns of overestimation and underestimation
across age strata differed by county. Percent differences
between the two population data sources ranged from <0.1%
to 64.1%. Discrepancies by age group were largest in San
Francisco County, where the percent difference between
DOF and census data was more than 30% in 4 of 10 age
groups for nHW women (ranging from -60.3% to 64.1%), and
in Marin County, where percent differences also exceeded
30% in 4 of 10 age groups (ranging from -32.9% to 41.4%).
More importantly, however, were discrepancies between pop-
ulation estimates for age groups with the highest incidence of
breast cancer; among nHW women aged 45 years and older,
the most substantial population data discrepancies were in
Marin County, where DOF population projections for nHW
women aged 45 to 64 years fell below census estimates by
approximately 31.7% and in San Benito County, where DOF
estimates for the 55 years and older population exceeded cen-
sus estimates by 30.6%. Age-specific discrepancies for Marin
County are plotted in Fig. 2.
Direct comparison of year 2000 DOF- and census-based age-
adjusted incidence rates by county revealed significant differ-
ences in estimated incidence rates by population source in
three of the ten counties under analysis (Table 2). Breast can-
Figure 2
Marin County, California, population estimates for non-Hispanic white  women by age and population data source (2000) Marin County, California, population estimates for non-Hispanic white 
women by age and population data source (2000). DOF, Department 
of Finance.
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cer incidence rates in Santa Clara and Los Angeles counties
were significantly lower when based on DOF county popula-
tion estimates compared to census county population data,
adjusting for age: the DOF-based rate was 143.4, 95% CI =
(137.5–149.5) versus the census-based rate of 158.6, 95%
CI = (152.0–165.4) in Santa Clara; and the DOF-based rate
was 153.8, 95% CI = (150.7–156.9) versus the census-
based rate of 161.0, 95% CI = (157.8–164.3) in Los Angeles.
Marin County was the only county where the DOF-based rate
was significantly higher than the census-based rate: the DOF-
based rate was 213.6, 95% CI = (198.4–229.9) versus the
census-based rate of 175.8, 95% CI = (163.2–189.5)). The
DOF-based rates for Marin County were approximately 22%
higher than census-based rates based on the same
numerators.
Discussion
These analyses have explored the extent to which use of inter-
censal population projections, extrapolated and 10 years
removed from the 1990 census, may have biased breast can-
cer incidence rates reported in California in the 1990s. DOF-
based incidence rates for Marin, Santa Clara, and Los Angeles
counties were found to differ significantly from census-based
incidence rates: county-specific DOF-based rates were lower
than census-based rates in Santa Clara and Los Angeles
counties, but higher than census-based rates in Marin County.
Direct comparison of year 2000 DOF and census population
data revealed accuracy of DOF projections at the state level,
although joint stratification of population estimates by county,
gender, race/ethnicity, and age introduced greater discrep-
ancy between population data sources. These discrepancies
between stratified population estimates were significant
enough to lead to notable differences in breast cancer inci-
dence rates, and can be expected to have a notable effect on
other statistics based on DOF intercensal estimates not
adjusted to the 2000 census. For example, in the case of San
Francisco County, substantial overestimation of the 5–14 year
old nHW female population (64.1%) by the DOF compared to
the 2000 US census, while having a negligible effect on
county breast cancer incidence rates due to the negligible rate
of breast cancer among this age group, may be anticipated to
have a notable impact on childhood cancer rates.
The fact that differences between population data sources
had a significant effect on breast cancer incidence rates in the
two largest counties analyzed (Los Angeles, population
9,519,338, and Santa Clara, population 1,682,585) and the
second smallest county analyzed (Marin, population 247,289)
suggests that population size is not responsible for variation
between census and DOF data. Indeed, no pattern of devia-
tion between the two population data sources is discernable
by county size, age distribution, or county urban/rural status. It
is possible that methods used by the census and methods
employed by the DOF are differentially effective among differ-
ent populations, or that differing levels of domestic migration
explains the discrepancies between these population data
sources. The source of these discrepancies, however, remains
unknown and was beyond the scope of this analysis.
One limitation to the applicability of this analysis is that DOF
intercensal population projections are not used as widely as
projections provided by the US census, as DOF projections
are only available for counties in the state of California; how-
Figure 3
Breast cancer incidence in Marin County, California, by population data source, and adjustment 2000 US census, for 1992–1999 Breast cancer incidence in Marin County, California, by population data source, and adjustment 2000 US census, for 1992–1999.
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ever, problems similar to those noted in this analysis have been
noted with the application of census projections [7]. Errors in
intercensal population projections provided by the US census
for the years 1991 to 1999 were recently implicated as a
source of significant overestimation of racial disparities in can-
cer incidence rates [7,15]. In Marin County, US census inter-
censal population projections were subject to error of closure
problems similar to those identified in DOF projections; cen-
sus projections, unadjusted to the 2000 US census, substan-
tially underestimated the high risk group of Marin County nHW
women aged 45 to 74 years (data not shown), resulting in an
overestimation of the overall incidence rate of breast cancer in
the latter years of the 1990s (Fig. 3). Thus, it is likely that sim-
ilar conclusions would have been reached had census inter-
censal projections been used rather than DOF intercensal
projections. Although methodology used to generate inter-
censal population projections by both the DOF and the Cen-
sus Bureau is intricate, complex, and complete, both agencies
have produced inaccurate projections. These error of closure
problems mean that population data, and incidence rates
based on these data, become less reliable as they become fur-
ther removed from the most recent census.
Conclusion
The California Cancer Registry, as well as county and local
governmental agencies and a broad range of community
organizations, must rely on intercensal population projections
to estimate health trends, allocate resources, and establish pri-
orities with respect to the populations they serve. Timely sur-
veillance requires that intercensal population projections be
used to generate population-based rates and trends as soon
as reliable incidence counts become available. This analysis,
however, demonstrates that intercensal population projections
can differ substantially from later decennial census counts.
Although it is unrealistic to recommend that disease surveil-
lance be paused in intercensal years, these data remind us
that population denominator quality can have a major impact
on the interpretation of health statistics. Health agencies must
judge whether aberrant health trends should be acted upon
prior to the release of population information that could inform
the accuracy of population projections, a process that could
take five years or more. The gravity of this problem is magnified
in the case of diseases like breast cancer that are the focus of
public concern and activism, which intensifies demand for
information and public health action.
The results of this analysis support the need for a restructuring
of population estimation procedures; perhaps more frequent
collection of population counts, particularly in regions experi-
encing high levels of migration. A 10-year period between
population censuses is problematic for accurate projection of
the age/gender/race-specific yearly population counts needed
for health tracking. Alternatively, government agencies
producing population projections would benefit from improve-
ments in ways to make more accurate assumptions regarding
the growth and distribution of the population. At the least,
more health agencies should develop better ways to describe
and quantify the uncertainties in population projections and
related bias to consumers of health statistics.
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